Search research articles
Contact Us
Filters
Showing results (1-10 of 72) with videos related to
Page
of 8
Sort By:
Current Radiopharmaceuticals
|
December 29, 2011
Actinium-225 in targeted alpha-particle therapeutic applications
David A Scheinberg, Michael R McDevitt
Critical Reviews in Oncogenesis
|
October 2, 2014
Fibrillous carbon nanotube: an unexpected journey
Michael R McDevitt, David A Scheinberg
Annual Review of Biomedical Engineering
|
January 19, 2018
Targeted and Nontargeted α-Particle Therapies
Michael R McDevitt, George Sgouros, Stavroula Sofou
Advanced Drug Delivery Reviews
|
June 3, 2008
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
Matthias Miederer, David A Scheinberg, Michael R McDevitt
Nature Reviews. Drug Discovery
|
September 8, 2020
Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Nature Reviews. Drug Discovery
|
July 31, 2020
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Crystals
|
May 13, 2021
Dialytic Separation of Bundled, Functionalized Carbon Nanotubes from Carbonaceous Impurities
J Justin Mulvey, Evan N Feinberg, Michael R McDevitt, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
December 15, 2005
Immunoreactivity assay for alpha-particle emitting monoclonal antibody constructs
Anthony S Bonavia, Michael R McDevitt, Michael J Curcio, et al.
Nanomedicine (London, England)
|
December 22, 2007
Targeted nanomaterials for radiotherapy
Freddy E Escorcia, Michael R McDevitt, Carlos H Villa, et al.
Nature Reviews. Clinical Oncology
|
March 31, 2010
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
David A Scheinberg, Carlos H Villa, Freddy E Escorcia, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 72) with videos related to
Sort By:
Page
of 8
Current Radiopharmaceuticals
|
December 29, 2011
Actinium-225 in targeted alpha-particle therapeutic applications
David A Scheinberg, Michael R McDevitt
Critical Reviews in Oncogenesis
|
October 2, 2014
Fibrillous carbon nanotube: an unexpected journey
Michael R McDevitt, David A Scheinberg
Annual Review of Biomedical Engineering
|
January 19, 2018
Targeted and Nontargeted α-Particle Therapies
Michael R McDevitt, George Sgouros, Stavroula Sofou
Advanced Drug Delivery Reviews
|
June 3, 2008
Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
Matthias Miederer, David A Scheinberg, Michael R McDevitt
Nature Reviews. Drug Discovery
|
September 8, 2020
Author Correction: Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Nature Reviews. Drug Discovery
|
July 31, 2020
Radiopharmaceutical therapy in cancer: clinical advances and challenges
George Sgouros, Lisa Bodei, Michael R McDevitt, et al.
Crystals
|
May 13, 2021
Dialytic Separation of Bundled, Functionalized Carbon Nanotubes from Carbonaceous Impurities
J Justin Mulvey, Evan N Feinberg, Michael R McDevitt, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
December 15, 2005
Immunoreactivity assay for alpha-particle emitting monoclonal antibody constructs
Anthony S Bonavia, Michael R McDevitt, Michael J Curcio, et al.
Nanomedicine (London, England)
|
December 22, 2007
Targeted nanomaterials for radiotherapy
Freddy E Escorcia, Michael R McDevitt, Carlos H Villa, et al.
Nature Reviews. Clinical Oncology
|
March 31, 2010
Conscripts of the infinite armada: systemic cancer therapy using nanomaterials
David A Scheinberg, Carlos H Villa, Freddy E Escorcia, et al.
Page
of 8